Orkila Capital
Finance · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
122 Hudson St Apt 4, New York, New York,...Website
www.orkilacapital.comRevenue
<$5 MillionIndustry
ZI Rank: 2
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
2
2
1
1
1
2
About Orkila Capital
Orkila Capital, established in 2013, specializes in growth equity investments within the media, entertainment, and consumer sectors. The firm's principals bring over 20 years of industry experience, focusing on unique brands, intellectual property, and valuable assets. Orkila Capital aims to identify and invest in compelling growth platforms that stand out in their respective markets. Their expertise and relationships in the industry enable them to pursue proprietary investment opportunities.Explore more
Orkila Capital Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Orkila Capital your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check if Orkila Capital has recently received funding, and reach out quickly before it becomes old news!
Check out if Orkila Capital is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Orkila Capital
Funding: Get notified immidiatlly once Orkila Capital has new funding data
Product Launch: Get notified when Orkila Capital launches new products
Orkila Capital, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Orkila Capital had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Orkila Capital recently announced quarterly report
Recommended Actions
Find VP level buyers at Orkila Capital
Find 2 more new buyers
Compare Similar Companies to Orkila Capital
Compare insights from companies similar to Orkila Capital, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Orkila Capital is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Orkila Capital is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Orkila Capital.
Orkila Capital Tech Stack
A closer look at the technologies used by Orkila Capital
Orkila Capital News & Media
Advance to Acquire the IRONMAN Group From Wanda Sports Group
Advance announced March 26, 2020, that it has entered into a definitive stock purchase agreement with Wanda Sports Group Company Limited (NASDAQ: WSG) to acquire The IRONMAN Group in an all-cash transaction. The IRONMAN Group and its portfolio of assets, which includes its flagship IRONMAN® and IRONMAN® 70.3® triathlons, the Rock 'n' Roll Marathon Series®, and the Epic Series® of mountain biking races, among other events, makes up the largest mass participation sports platform inCannamedical Receives €15M Equity Investment from Orkila Capital
Cannamedical Pharma GmbH, a Cologne, Germany-based independent cannabis wholesaler, received €15m in Series A funding. US- and Germany-based Orkila Capital made a minority equity investment in the company. Founded in 2016 by David Henn, CEO, Cannamedical Pharma imports medical cannabis products and distribute them to around 2,000 pharmacies and clinical facilities to help doctors, healthcare […] The post Cannamedical Receives €15M Equity Investment from Orkila Capital appeared first on FinSMEs.Cannamedical receives EUR15m equity investment from Orkila Capital
Cannamedical Pharma, an independent cannabis wholesaler in Germany and the European Union, has received a EUR15 million equity investment from the US- and Germany-based growth equity investment firm Orkila Capital.Cannamedical® Receives Euro 15 Million Equity Investment from Orkila Capital
COLOGNE, Germany--(BUSINESS WIRE)--Cannamedical Pharma GmbH, one of the leading independent cannabis wholesalers in Germany and the European Union, has received a 15-million-euro equity investment from the US- and Germany-based growth equity investment firm Orkila Capital LLC. As a result of its investment, Orkila Capital has acquired a minority in Cannamedical. "I am very pleased that Orkila Capital has recognized our growth potential and chosen to invest in us. Our most important goal is to e
Read more news
Top Finance Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Orkila Capital
Sign Up For FreeTo access detailed company insights
Orkila Capital, established in 2013, specializes in growth equity investments within the media, entertainment, and consumer sectors. The firm's principals bring over 20 years of industry experience, focusing on unique brands, intellectual property, and valuable assets. Orkila Capital aims to identify and invest in compelling growth platforms that s... Read More
